23andMe, the Mountain View genetics testing company, has received approval from the Food and Drug Administration to sell tests that indicate people’s risk of developing 10 diseases including Parkinson’s, Alzheimer’s, Celiac and some blood clotting disorders. In 2013, the agency ordered 23andMe to suspend the sale of its flagship product, which analyzed...